Form 4 General Mills For: 8 July

Form 4 General Mills For: 8 July

Form 4 General Mills For: 8 July
Every few months, a new piece appears questioning whether technology will finally make the mortgage adviser obsolete. Most recently, The Financial Times asked whether artificial intelligence (AI) could signal the end of the mortgage broker, reflecting a wider debate about how consumers will access financial products in the future. Or, indeed, how they are…
Jeff Bezos attends the Viva Technology show at Parc des Expositions on June 17, 2026 in Paris, France. Chesnot | Getty Images Entertainment | Getty Images Jeff Bezos‘ Blue Origin is raising about $10 billion, in its first outside funding round that will value the rocket company at $130 billion, sources told CNBC’s Andrew Ross…
Key insight: As AI-assisted coding becomes more common and economically viable, the burden on automated testing suites increases. What’s at stake: The limiting factor in payment infrastructure will not be whether teams can produce more code. It will be whether they can prove that sensitive logic still behaves safely across the messy reality of production…
Stress-tested Liquidity, Gold Volatility & Dubai Growth | Andreas Kapsos, CEO of Match-Prime Stress-tested Liquidity, Gold Volatility & Dubai Growth | Andreas Kapsos, CEO of Match-Prime Stress-tested Liquidity, Gold Volatility & Dubai Growth | Andreas Kapsos, CEO of Match-Prime Stress-tested Liquidity, Gold Volatility & Dubai Growth | Andreas Kapsos, CEO of Match-Prime Stress-tested Liquidity, Gold…
You’re Missing Out! Members can reply to discussions, connect with experienced landlords, and access full member profiles showing years of expertise. Don’t stay on the sidelines – join the UK’s most active landlord community today. Not a member yet? Join In Seconds or if you’re already a member Login with
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. As new GLP-1 drugs enter the U.S. market and landmark Medicare coverage rolls out, one thing remains the same: Most employers still aren’t covering those drugs for…